Dr. Jyotsna Priyam
IIT Mandi · ICGEB · AI-Driven Digital Health · Founder, Biomedical AI Platforms
Insilico Medicine's AI-Designed Drug Clears Phase 2a for Idiopathic Pulmonary Fibrosis
Both the drug and its target were designed by AI. It just cleared phase 2a for a serious lung disease.
Roche and Eli Lilly's Blood-Based Alzheimer's Test Wins First FDA Clearance for Primary Care
A simple blood test can now rule out Alzheimer's with 97.9% accuracy, right from your family doctor's office.
Ultima Genomics Hits Single-Digit PPM Sensitivity for ctDNA Cancer Recurrence Detection
Finding one drop of ink in a swimming pool — that's roughly the scale of what Ultima Genomics' new cancer-detection tech just pulled off.
AI Drug Discovery Is Shifting From Reading Genetic Code to Understanding What It Does
Knowing every word in a dictionary doesn't mean you understand a language. Most AI models in biology have the same problem.
One of the Most Consequential Years for Cancer Treatment, Ever
Is 2026 really a turning point for cancer treatment, or does it just feel that way? STAT makes a compelling case for the former.
FDA Approves Daraxonrasib, First Drug to Directly Attack Pancreatic Cancer's Genetic Driver
For decades, mutant KRAS was called undruggable. A newly approved pancreatic cancer pill just proved that label wrong.
The Secret Ingredient in Merck & Moderna's Cancer Vaccine Is an Algorithm
A cancer vaccine whose genetic sequence was written by an algorithm, not a chemist. It just cleared a late-stage trial.
When AI Starts Reading the Genome: The Biotech Signals to Watch
Three stories from the last few weeks convinced me AI has stopped being a tool bolted onto biotech — it's becoming the infrastructure underneath it.